All News AroCell AB

Equities

Delayed Nasdaq Stockholm Other stock markets 10:19:38 2024-06-28 EDT			5-day change	1st Jan Change
0.426 ^SEK	-1.84%		+6.50%	-2.52%

05-03	AroCell AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-18	Swedish Diagnostics Company AroCell Secures US Patent	MT

AroCell : Airlangga University and Dr. Soetomo General Hospital Visit AroCell and IDL offic	06-19	PU
AroCell : Laboratory Engineer	06-14	PU
AroCell AB (publ) Interim Report January 1st to March 31st, 2024	05-06	AQ
AroCell Q1 - Unrecognized and going well	05-06	AQ
AroCell AB (publ) Interim Report January 1st to March 31st, 2024	05-03	AQ
AroCell AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-03	CI
AroCell - New patent approved on the US market	04-19	AQ
Swedish Diagnostics Company AroCell Secures US Patent	04-18	MT
New patent approved on the US market	04-18	AQ
AroCell Attends Three Prestigious Events: AACR, EAU Congress and COG Nordics	04-16	PU
AroCell publishes the Annual Report for 2023	04-15	AQ
AroCell publishes the Annual Report for 2023	04-12	AQ
The nomination committee's proposal for the board of AroCell for the Annual General Meeting 2024	03-12	AQ
New Study: UBC Rapid can reduce the number of cystoscopies necessary in bladder cancer patients, enabling cost-effective follow-up	03-12	AQ
Two Accepted Abstracts at AACR 2024 Explore Clinical Applications of TK1 Biomarker	03-11	AQ
AroCell : Presentation at LabRoots 2024	03-04	PU
AroCell Q4 - Nearing positive operating cash flow	02-23	AQ
AroCell AB (publ) Interim Report January 1st to December 31st, 2023	02-22	AQ
AroCell AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-22	CI
AroCell AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-22	CI

No results for this search